Pfizer (NYSE:PFE) Coverage Initiated by Analysts at Guggenheim

Guggenheim initiated coverage on shares of Pfizer (NYSE:PFE – Free Report) in a research report sent to investors on Friday, Marketbeat Ratings reports. The firm issued a buy rating and a $36.00 target price on the biopharmaceutical company’s stock. Other equities analysts have also issued research reports about the stock. Cantor Fitzgerald reiterated an overweight […]

Related Keywords

Scott Gottlieb ,Securities Exchange Commission ,Pfizer ,Pfizer Company Profile ,Morgan Stanley ,Charles Schwab Investment Management Inc ,Pfizer Inc ,Geode Capital Management ,Cantor Fitzgerald ,Barclays ,Moneta Group Investment Advisors ,Free Report ,Marketbeat Ratings ,Get Free Report ,Director Scott Gottlieb ,Exchange Commission ,Street Corp ,Group Investment Advisors ,Capital Management ,Schwab Investment Management ,Pfizer Daily ,Nyse Pfe ,Pfe ,Medical ,71708110 ,Initiated Coverage ,Guggenheim ,